Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Perkins

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Journal of Insurance Medicine (New York, N.Y.)|August 3, 2005
The role of the medical director in the risk assessment processJ Daniel Perkins
Journal of Pain & Palliative Care Pharmacotherapy|October 21, 2024
Changes in Pain and Mental Health Symptoms Associated with Prescribed Medicinal Cannabis Use: A One-Year Longitudinal StudyAndreas Halman, Richard Chenhall, Daniel Perkins
Journal of Children'S Services|November 27, 2015
Piloting a classroom-based intervention in after-school programmes: a case study in science migrationKathryn Hynes, Emilie Phillips Smith, Daniel Perkins
JAMA|December 21, 2021
Legalization of Psychedelic SubstancesLuke A Downey, Jerome Sarris, Daniel Perkins
Journal of Psychopharmacology (Oxford, England)|November 20, 2023
Drug-drug interactions involving classic psychedelics: A systematic reviewAndreas Halman, Geraldine Kong, Jerome Sarris, et al.
Environmental Toxicology and Chemistry|January 18, 2018
Assessing and mitigating simulated population-level effects of 3 herbicides to a threatened plant: Application of a species-specific population model of Boltonia decurrensAmelie Schmolke, Richard Brain, Pernille Thorbek, et al.
Annals of the New York Academy of Sciences|September 23, 2024
Artificial intelligence and psychedelic medicineJerome Sarris, Andreas Halman, Anna Urokohara, et al.
Environmental Toxicology and Chemistry|August 7, 2016
Population modeling for pesticide risk assessment of threatened species-A case study of a terrestrial plant, Boltonia decurrensAmelie Schmolke, Richard Brain, Pernille Thorbek, et al.
International Journal of Toxicology|February 16, 2024
Ayahuasca and Dimethyltryptamine Adverse Events and Toxicity Analysis: A Systematic Thematic ReviewEleanor White, Tom Kennedy, Simon Ruffell, et al.
Epilepsy & Behavior : E&B|May 20, 2026
Effectiveness and tolerability of cannabidiol in paediatric epilepsy: a one-year multisite prospective studyAndreas Halman, Jeremy L Freeman, Michael Fahey, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Journal of Insurance Medicine (New York, N.Y.)|August 3, 2005
The role of the medical director in the risk assessment processJ Daniel Perkins
Journal of Pain & Palliative Care Pharmacotherapy|October 21, 2024
Changes in Pain and Mental Health Symptoms Associated with Prescribed Medicinal Cannabis Use: A One-Year Longitudinal StudyAndreas Halman, Richard Chenhall, Daniel Perkins
Journal of Children'S Services|November 27, 2015
Piloting a classroom-based intervention in after-school programmes: a case study in science migrationKathryn Hynes, Emilie Phillips Smith, Daniel Perkins
JAMA|December 21, 2021
Legalization of Psychedelic SubstancesLuke A Downey, Jerome Sarris, Daniel Perkins
Journal of Psychopharmacology (Oxford, England)|November 20, 2023
Drug-drug interactions involving classic psychedelics: A systematic reviewAndreas Halman, Geraldine Kong, Jerome Sarris, et al.
Environmental Toxicology and Chemistry|January 18, 2018
Assessing and mitigating simulated population-level effects of 3 herbicides to a threatened plant: Application of a species-specific population model of Boltonia decurrensAmelie Schmolke, Richard Brain, Pernille Thorbek, et al.
Annals of the New York Academy of Sciences|September 23, 2024
Artificial intelligence and psychedelic medicineJerome Sarris, Andreas Halman, Anna Urokohara, et al.
Environmental Toxicology and Chemistry|August 7, 2016
Population modeling for pesticide risk assessment of threatened species-A case study of a terrestrial plant, Boltonia decurrensAmelie Schmolke, Richard Brain, Pernille Thorbek, et al.
International Journal of Toxicology|February 16, 2024
Ayahuasca and Dimethyltryptamine Adverse Events and Toxicity Analysis: A Systematic Thematic ReviewEleanor White, Tom Kennedy, Simon Ruffell, et al.
Epilepsy & Behavior : E&B|May 20, 2026
Effectiveness and tolerability of cannabidiol in paediatric epilepsy: a one-year multisite prospective studyAndreas Halman, Jeremy L Freeman, Michael Fahey, et al.
Pageof 5